To address rising threat of antimicrobial resistance, India’s drug regulator plans an overhaul of regulations for antibiotics, including ban on OTC sales, improving tracking of use, and promoting development of new antibiotics, aiming to curb the public health crisis resulting in significant deaths.

Read more